4//SEC Filing
OTTO MICHAEL J. 4
Accession 0001209191-11-054808
CIK 0001301081other
Filed
Nov 6, 7:00 PM ET
Accepted
Nov 7, 6:16 PM ET
Size
9.1 KB
Accession
0001209191-11-054808
Insider Transaction Report
Form 4
Pharmasset IncVRUS
OTTO MICHAEL J.
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2011-11-01$10.83/sh+17,500$189,525→ 17,500 total - Sale
Common Stock
2011-11-01$74.56/sh−17,500$1,304,800→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2011-11-01−17,500→ 0 totalExercise: $10.83Exp: 2019-10-14→ Common Stock (17,500 underlying)
Footnotes (3)
- [F1]This transaction is the result of standing instructions set forth in a Rule 10b5-1 plan previously established by filer.
- [F2]The number of shares beneficially owned reflected in Items 5 and 9 of this Form 4 represent a two-for-one stock split (the "Split") of the Issuer's common stock which is structured in the form of a dividened payable on August 31, 2011 to the stockholders of record at the close of business August 22, 2011.
- [F3]A total of 20,000 pre-Split (40,000 post-Split) options were granted on 10/14/2009. Shares vest on the following schedule: 25% on the first anniversary of the grant, and 6.25% quarterly thereafter.
Documents
Issuer
Pharmasset Inc
CIK 0001301081
Entity typeother
Related Parties
1- filerCIK 0001284621
Filing Metadata
- Form type
- 4
- Filed
- Nov 6, 7:00 PM ET
- Accepted
- Nov 7, 6:16 PM ET
- Size
- 9.1 KB